Want to see JP:7702 full AI Analyst Report?
Top Page
JMS Co., Ltd.
(7702)
Select Model
Select Model
Rating:52Neutral
Price Target:
¥470.00
▲(6.33% Upside)
Action:Reiterated
Date:08/17/26
The score is held down primarily by weak financial performance—profitability has deteriorated into a recent net loss and free cash flow has been volatile and often negative—despite a relatively stable balance sheet. Technicals are a positive offset with the price above key moving averages and constructive momentum indicators. Valuation is only modestly supportive due to a negative P/E, partially balanced by a ~3.66% dividend yield.
Positive Factors
Stable Balance Sheet
The equity cushion and moderate debt load provide financial resilience and support ongoing operations. Although leverage has risen, the balance sheet remains sufficiently stable to absorb near-term earnings weakness.
Negative Factors
Revenue Contraction
Declining revenue signals weaker demand, volume, pricing, or market execution and limits operating leverage. If this trend persists, it can make fixed costs harder to absorb and further pressure margins and profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Stable Balance Sheet
The equity cushion and moderate debt load provide financial resilience and support ongoing operations. Although leverage has risen, the balance sheet remains sufficiently stable to absorb near-term earnings weakness.
Read all positive factors
JMS Co., Ltd. (7702) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥11.29B
Dividend Yield3.71%
Average Volume (3M)25.96K
Price to Earnings (P/E)―
Beta (1Y)0.58
Revenue Growth-5.34%
EPS Growth-152.53%
CountryJP
Employees4,887
SectorGeneral
Sector StrengthN/A
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-28.66
Shares Outstanding24,733,465
10 Day Avg. Volume29,090
30 Day Avg. Volume25,963
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.25
Price to Sales (P/S)0.16
P/FCF Ratio-11.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
JMS Co., Ltd. Business Overview & Revenue Model
Company Description
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both...
How the Company Makes Money
null...
JMS Co., Ltd. Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
58
Neutral
Cash Flow
38
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.43B | 65.84B | 69.75B | 65.29B | 63.74B | 58.17B |
| Gross Profit | 15.49B | 15.36B | 15.93B | 14.09B | 14.60B | 14.27B |
| EBITDA | 4.66B | 4.22B | 4.79B | 4.08B | 4.38B | 4.59B |
| Net Income | -704.00M | -784.00M | 89.00M | -36.00M | 281.00M | 826.00M |
Balance Sheet | ||||||
| Total Assets | 82.82B | 83.07B | 81.43B | 84.71B | 74.41B | 71.97B |
| Cash, Cash Equivalents and Short-Term Investments | 8.78B | 7.72B | 5.51B | 10.31B | 6.33B | 6.81B |
| Total Debt | 26.15B | 28.01B | 24.55B | 26.92B | 19.75B | 18.71B |
| Total Liabilities | 41.10B | 41.27B | 40.50B | 43.96B | 35.70B | 34.87B |
| Stockholders Equity | 41.66B | 41.73B | 40.84B | 40.57B | 38.53B | 36.96B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -892.00M | -1.42B | 498.00M | -1.07B | 1.14B |
| Operating Cash Flow | 0.00 | 1.58B | 1.47B | 3.14B | 2.48B | 4.40B |
| Investing Cash Flow | 0.00 | -2.25B | -3.14B | -4.24B | -3.69B | -3.68B |
| Financing Cash Flow | 0.00 | 2.69B | -3.19B | 4.78B | 525.00M | -499.00M |
JMS Co., Ltd. Technical Analysis
Positive
442.00
Price Trends
455.34
Positive
442.98
Positive
436.75
Positive
Market Momentum
1.32
Negative
51.54
Neutral
57.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7702, the sentiment is Positive. The current price of 442 is below the 20-day moving average (MA) of 454.35, below the 50-day MA of 455.34, and above the 200-day MA of 436.75, indicating a bullish trend. The MACD of 1.32 indicates Negative momentum. The RSI at 51.54 is Neutral, neither overbought nor oversold. The STOCH value of 57.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7702.
JMS Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥3.80T | 22.96 | 9.19% | 1.39% | 14.05% | 31.94% | |
72 Outperform | ¥1.04T | 32.18 | 19.68% | 1.36% | 21.16% | 157.04% | |
69 Neutral | ¥2.35T | 30.18 | 8.94% | 1.65% | 7.80% | -27.73% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | ¥11.29B | -15.98 | ― | 3.85% | -5.34% | -152.53% | |
48 Neutral | ¥256.47B | 17.81 | 5.37% | 2.03% | 2.68% | 144.20% |
* General Sector Average
JP:7702
JMS Co., Ltd.
458.00
25.79
5.97%
JP:4543
Terumo
2,560.00
-68.05
-2.59%
JP:7747
Asahi Intecc Co
3,862.00
1,376.15
55.36%
JP:8086
Nipro
1,532.00
58.63
3.98%
JP:7733
Olympus
2,141.50
439.54
25.83%
JMS Co., Ltd. Corporate Events
JMS Posts Narrower Losses but Lower Sales in Q1 FY2026 While Maintaining Dividend Outlook
Aug 7, 2026
JMS Co., Ltd. reported consolidated net sales of ¥15,128 million for the first quarter ended June 2026, a 2.7% year-on-year decline, with operating and ordinary losses narrowing slightly compared with the prior year and profit attributable to...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.